Overview

Study of SyB P-1501 (Fentanyl HCI) for Treatment of Postoperative Pain

Status:
Unknown status
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
This is a Phase 3 clinical trial to compare the safety and efficacy of SyB P-1501 with the SyB P-1501 placebo for the management of the first 24 hours of post-operative pain.
Phase:
Phase 3
Details
Lead Sponsor:
SymBio Pharmaceuticals
Collaborator:
Yutoku Pharmaceutical
Treatments:
Fentanyl